Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor

Established Pharmacologic Class (EPC) Comparison, United States, 2022

ClinCalc.com » Pharmacy » ClinCalc DrugStats » Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor

Total Prescriptions in (2022)

Total Prescriptions by Drug Over Time

Drug Class Prescribing Trends Over Time

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2013-2022. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2024.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).